- Home
- IT vs XOMAO Comparison
IT vs XOMAO Comparison
Compare IT & XOMAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IT
- XOMAO
- Stock Information
- Founded
- IT 1979
- XOMAO N/A
- Country
- IT United States
- XOMAO United States
- Employees
- IT N/A
- XOMAO 13
- Industry
- IT Other Consumer Services
- XOMAO Biotechnology: Pharmaceutical Preparations
- Sector
- IT Consumer Discretionary
- XOMAO Health Care
- Exchange
- IT Nasdaq
- XOMAO Nasdaq
- Market Cap
- IT 30.7B
- XOMAO N/A
- IPO Year
- IT 1993
- XOMAO N/A
- Fundamental
- Price
- IT $405.90
- XOMAO $25.46
- Analyst Decision
- IT Buy
- XOMAO
- Analyst Count
- IT 8
- XOMAO 0
- Target Price
- IT $514.00
- XOMAO N/A
- AVG Volume (30 Days)
- IT 842.4K
- XOMAO N/A
- Earning Date
- IT 07-29-2025
- XOMAO N/A
- Dividend Yield
- IT N/A
- XOMAO N/A
- EPS Growth
- IT 59.64
- XOMAO N/A
- EPS
- IT 16.06
- XOMAO N/A
- Revenue
- IT $6,328,615,000.00
- XOMAO N/A
- Revenue This Year
- IT $7.88
- XOMAO N/A
- Revenue Next Year
- IT $6.71
- XOMAO N/A
- P/E Ratio
- IT $25.17
- XOMAO N/A
- Revenue Growth
- IT 5.99
- XOMAO N/A
- 52 Week Low
- IT $366.05
- XOMAO N/A
- 52 Week High
- IT $584.01
- XOMAO N/A
- Technical
- Relative Strength Index (RSI)
- IT 39.87
- XOMAO 59.29
- Support Level
- IT $390.16
- XOMAO $25.35
- Resistance Level
- IT $408.56
- XOMAO $25.41
- Average True Range (ATR)
- IT 7.31
- XOMAO 0.05
- MACD
- IT 0.24
- XOMAO 0.01
- Stochastic Oscillator
- IT 40.33
- XOMAO 100.00
About IT Gartner Inc.
Gartner Inc provides independent research and analysis on information technology and other related technology industries. Its research is delivered to clients' desktops in the form of reports, briefings, and updates. Typical clients are chief information officers and other business executives who help plan companies' IT budgets. Gartner also provides consulting services. The company operates through three business segments, namely Research, Conferences and Consulting. The company generates majority of the revenue from Research segment.
About XOMAO AGNC Investment Corp.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.